androstenediol has been researched along with Thrombopenia in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 3 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahlem, C; Dowding, C; Frincke, J; Garsd, A; McKeon, M; Reading, C; Stickney, DR; Whitnall, M | 1 |
| Authier, S; Dowding, C; Frincke, JM; Garsd, A; Onizuka-Handa, N; Reading, C; Stickney, DR | 1 |
| Elliott, TB; Jackson, WE; Kumar, KS; Landauer, MR; Ledney, GD; Mckinney, L; Seed, TM; Srinivasan, V; Whitnall, MH; Wilhelmsen, CL | 1 |
3 other study(ies) available for androstenediol and Thrombopenia
| Article | Year |
|---|---|
5-androstenediol stimulates multilineage hematopoiesis in rhesus monkeys with radiation-induced myelosuppression.
Topics: Androstenediol; Anemia; Animals; Female; Hematopoiesis; Macaca mulatta; Male; Neutropenia; Particle Size; Radiation Injuries, Experimental; Thrombocytopenia; Whole-Body Irradiation | 2006 |
5-androstenediol improves survival in clinically unsupported rhesus monkeys with radiation-induced myelosuppression.
Topics: Androstenediol; Animals; Female; Gamma Rays; Macaca mulatta; Male; Radiation Injuries, Experimental; Radiation-Protective Agents; Thrombocytopenia; X-Rays | 2007 |
In vivo protection against gamma-irradiation with 5-androstenediol.
Topics: Androstenediol; Animals; Female; Gamma Rays; Killer Cells, Natural; Leukocyte Count; Male; Mice; Monocytes; Neutropenia; Radiation Injuries; Radiation-Protective Agents; Thrombocytopenia; Whole-Body Irradiation | 2001 |